Angiotensin receptor blockers reduce no-reflow post-PCI
(HealthDay) -- For patients with acute myocardial infarction (AMI), pretreatment with angiotensin receptor blockers (ARBs) is linked with reduced incidence of the no-reflow phenomenon after percutaneous coronary intervention ...
Apr 24, 2012
0
0